Administration of methylene blue in human septic shock: Renaissance of an old drug? [6] (multiple letters)

Critical Care Medicine

Volumn 31, Issue 5, 2003, Pages 1601-1603

  Evgenov, Oleg V ^a   Bjertnaes, Lars J ^b   Donati, Abele ^c   Loggi, Silvia ^c   Pelaia, Paolo ^c   Pietropaoli, Paolo ^d   Preiser, Jean Charles ^f   Fabiola, Reine ^e  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^c UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e ERASME HOSPITAL   (Belgium)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

METHYLENE BLUE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFECT; DRUG SAFETY; HEART FUNCTION; HUMAN; HYDROSTATIC PRESSURE; LETTER; LUNG TOXICITY; LUNG VASOCONSTRICTION; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; PUBLICATION; SEPTIC SHOCK; SIDE EFFECT; TREATMENT OUTCOME; VASCULAR RESISTANCE;

BLOOD VOLUME; CAPILLARY PERMEABILITY; GUANYLATE CYCLASE; HUMANS; METHYLENE BLUE; RESEARCH DESIGN; RISK FACTORS; SHOCK, SEPTIC; VASOCONSTRICTOR AGENTS;

EID: 0037566758     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000065671.24509.4B     Document Type: Letter

References (0)